MedTrace Logo

Randomized Study to Compare the Bioavailability of Three Halobetasol Propionate 0.05% Topical Creams

NCT00803166 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-10-18

No results posted yet for this study

Summary

The purpose of this study was to compare the relative vasoconstrictive effects of two test and one reference Halobetasol Propionate 0.05% Cream in healthy, female subjects.

Conditions

  • Healthy

Interventions

DRUG

Halobetasol Propionate 0.05% Cream-Reference Product

Small amount applied and evaluated over the course of three days

DRUG

Halobetasol Propionate 0.05% Cream-Test product 1

Small amount applied and evaluated over the course of three days

DRUG

Halobetasol Propionate 0.05% Cream-Test Product 2

Small amount applied and evaluated over the course of three days

Sponsors & Collaborators

  • Padagis LLC

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2004-01-31
Completion
2004-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00803166 on ClinicalTrials.gov